Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-06-20
1986-06-24
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544250, 544284, 546335, A61K 31505, C07D48704
Patent
active
045968063
ABSTRACT:
7-Piperidino-1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-one having platelet aggregation inhibitory activity is disclosed. The compound has high water-solubility and reduced influences on the circulatory system.
REFERENCES:
patent: 3932407 (1976-01-01), Beverung, Jr. et al.
patent: 3983119 (1976-09-01), Beverung, Jr. et al.
patent: 3983120 (1976-09-01), Beverung, Jr. et al.
patent: 4208521 (1980-06-01), Crenshaw et al.
patent: 4256748 (1981-03-01), Chodnekar et al.
patent: 4455311 (1984-06-01), Kienzle
Ashida Shinichiro
Ishikawa Fumiyoshi
Daiichi Seiyaku Co., Ltd.
Daus Donald G.
Rivers Diana G.
LandOfFree
7-piperidino-1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-one h does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-piperidino-1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-one h, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-piperidino-1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-one h will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2085466